타액선 선양낭성암종에서 혈관형성 신호전달 물질의 발현과 미세혈관농도에 관한 면역조직화학적 연구
Immunohistochemical assays for the expression of angiogenic signaling molecules and microvessel density in adenoid cystic carcinomas of human salivary glands
1
조회
0
다운로드
3
인용
0
참고문헌
초록
Abstract
Adeonoid cystic carcinoma (ACC) is one of the most common malignant tumors of salivary glands. It is characterized by a relentless regrowth especially around nerve tissues and a high rate of hematogenous distant metastasis. Clinically most deaths from salivary ACC are caused by delayed lung metastases that are resistant to conventional chemotherapy. So, knowledge of cellular and molecular properties that influence the dissemination of metastatic tumor cells, is important for new treatment strategies of metastatic lesions. We determined expressions of angiogenic signaling molecules microvessel density (MVD) using surgical specimens of human salivary ACC. Protein expressions of vascular endothelial growth factor (VEGF), VEGF receptor (VEGFR)-2, activated VEGFR-2, and human CD31 were assessed in 20 cases of salivary ACC by immunohistochemical staining. Most of the tumors, especially ACC with a tubulocribriform pattern, were positive for antibodies of VEGF, VEGFR-2, and activated VEGFR-2. The overall percentages of the 20 specimens expressing VEGF, VEGFR-2, activated VEGFR-2 were 90, 95, and 95%, respectively. Immunoreactivities of the biomarkers in salivary ACC were higher than those in normal salivary gland. Furthermore, immune-related cells as well as tumor cells expressed VEGF/VEGFR-2. Microvessel density of salivary ACC was higher than that of normal salivary gland (P<0.05). Taken together, angiogenic signaling molecules are actively expressed in salivary ACC. And we suggest that these molecules may have critical role in the hematogenous spread of salivay ACC, which has a propensity for delayed lung metastasis. Therefore, these biomarkers can be molecular targets for therapy of metastasis of salivary ACC.
참고문헌 (29)
- "Salivary neoplasms,overview of a 35 year experience with 2,807 patients", 8, pp.177~184 (1986)
- "Histopathologic grading of salivary gland neoplasms.III.Adenoid cystic carcinomas", 99, pp.1007~1009 (1990)
- "Adenoid cystic carcinoma of the head and neck:predictors of morbidity and mortality", 125, pp.149~152 (1999)
- "Distant metastasis in adenoid cystic carcinoma of salivary origin", 174, pp.495~498 (1997)
- "Vascular endothelial growth factor(VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study", 119, pp.732~738 (1999)
- "Expression of growth factors and their receptors in invasive breast cancer Correlations with proliferation and angiogenesis", 184, pp.53~57 (1998)
- "Human oral squamous cell carcinoma cell lines promote angiogenesis via expression of vascular endothelial growth factor and upregulation of KDR", flk-1 expression in endothelial cells, 2000, pp.36, 81~88
- "Vascular endothelial growth factor induces endothelial fenestrations in vitro", 140, pp.947~959 (1998)
- "Interleukin-8 as a macrophage-derived mediator of angiogenesis", 258, pp.1798~1801 (1992)
- "Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck", 5, pp.775~782 (1999)
- "Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis", 151, pp.1105~1113 (1997)
- "Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis", 2, pp.737~744 (2000)
- "Transforming growth factoralpha-induced transcriptional activation of the vascular permeability factor (VPF", VEGF) gene requires AP-2-dependent DNA binding and transactivation, 1997, pp.16, 750~759
- "Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release", 37, pp.77~83 (2001)
- "Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells", 273, pp.13313~13316 (1998)
- "Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal", 103, pp.159~165 (1999)
- "Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck", 29, pp.585~589 (2002)
- "Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice", 90, pp.447~454 (1998)
- "Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade", 64, pp.7977~7984 (2004)
- "A decade of tyrosine kinases:from gene discovery to therapeutics", 12, pp.39~49 (2003)
- "Molecular and biological properties of the vascular endothelial growth factor family of proteins", 13, pp.18~32 (1992)
- "Malignant neoplasm of the minor salivary glands", 306, pp.718~722 (1982)
- "Intra-tumoural microvessel density in human solid tumoures", 86(10), pp.1566~1577 (2002)
- "Quantitative angiogenesis assays in vivo-a review", 7, pp.1~16 (2004)
- "Quantification of angiogenesis in solid human tumoures An international consensus on the methodology and criteria of evaluation", 32A(14), pp.2474~2484 (1996)
- "Vascular endothelial growth factor as a marker of tumor endothelium", 58(9), pp.1952~1959 (1998)
- "CD105 is important for angiogenesis: Evidence and potential applications", 17(9), pp.984~992 (2003)
- "Clinico-pathological significance of microvessel density and vascular endothelial growth factor expression in adenoid cystic carcinoma of salivary glands", 36(3), pp.212~214 (2001)
- "Microvessel density and expression of vascular endothelial growth factor in adenoid cystic carcinoma of salivary gland", 12, pp.443~446 (2003)
